OpenLegislation

Regulation 2 Amendments to the Misuse of Drugs Regulations 2001

Original text. Later amendments are not shown.

(1)

The Misuse of Drugs Regulations 2001f1 are amended as follows.

(2)

In paragraph 1(a) of Schedule 3 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 22, 23, 24, 26 and 27)—

(a)

after “Flunitrazepam” insert—

“

Gabapentin (1–(aminomethyl)cyclohexaneacetic acid)

”;

(b)

after “Pipradrol” insert—

“

Pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid)

”.

(3)

In paragraph 3 of Schedule 3, for “Any ester or ether of pipradrol.” substitute—

“Any—

(a)

ester or ether of pipradrol; or

(b)

ester of gabapentin (1–(aminomethyl)cyclohexaneacetic acid) or pregabalin ((S)–3–(aminomethyl)-5-methylhexanoic acid).”.

Annotations

Footnotes

f1

S.I. 2001/3998. Relevant amending instruments are S.I. 2003/2429, 2004/1031, 2004/1771, 2005/271, 2005/2864, 2006/986, 2006/1450, 2006/2178, 2007/2154, 2011/2581, 2012/973, 2012/1311, 2012/1916, 2013/235, 2014/1275, 2015/891 and 2018/682.